Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-06-15 7:11 pm Unchanged |
2022-06-13 | 13D | Tyra Biosciences, Inc. TYRA |
Boxer Capital LLC | 6,323,359 15.100% |
0 (Unchanged) |
Filing History |
| 2022-03-24 4:22 pm Purchase |
2022-03-14 | 13G | Tyra Biosciences, Inc. TYRA |
BIOTECHNOLOGY VALUE FUND L P | 2,472,327 5.900% |
2,472,327 (New Position) |
Filing History |
| 2022-02-09 10:01 am Purchase |
2022-02-08 | 13G | Tyra Biosciences, Inc. TYRA |
FMR LLC | 3,468,831 8.406% |
3,468,831 (New Position) |
Filing History |
| 2022-02-08 3:28 pm Purchase |
2021-12-31 | 13G | Tyra Biosciences, Inc. TYRA |
Canaan XI L.P. | 3,936,595 9.500% |
3,936,595 (New Position) |
Filing History |
| 2021-09-29 06:01 am Unchanged |
2021-09-15 | 13G | Tyra Biosciences, Inc. TYRA |
TCG Crossover Management LLC | 937,500 2.200% |
0 (Unchanged) |
Filing History |
| 2021-09-27 4:36 pm Purchase |
2021-09-17 | 13G | Tyra Biosciences, Inc. TYRA |
NEXTECH VI ONCOLOGY SCSP | 2,518,582 5.900% |
2,518,582 (New Position) |
Filing History |
| 2021-09-27 4:30 pm Purchase |
2021-09-17 | 13D | Tyra Biosciences, Inc. TYRA |
Alta Partners NextGen Fund II Management LLC | 4,080,296 9.600% |
4,080,296 (New Position) |
Filing History |
| 2021-09-27 4:30 pm Purchase |
2021-09-17 | 13D | Tyra Biosciences, Inc. TYRA |
RA Capital Management, L.P. | 7,236,454 17.000% |
7,236,454 (New Position) |
Filing History |
| 2021-09-24 4:30 pm Purchase |
2021-09-17 | 13D | Tyra Biosciences, Inc. TYRA |
Boxer Capital LLC | 6,323,359 14.900% |
6,323,359 (New Position) |
Filing History |
| 2021-09-21 12:16 pm Purchase |
2021-09-15 | 13G | Tyra Biosciences, Inc. TYRA |
TCG Crossover Management LLC | 937,500 8.700% |
937,500 (New Position) |
Filing History |